|4Aug 29, 5:08 PM ET

Downey Gregory 4

4 · Lexaria Bioscience Corp. · Filed Aug 29, 2022

Insider Transaction Report

Form 4
Period: 2022-08-29
Downey Gregory
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2022-08-29+11,00046,000 total
    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29Common Shares (11,000 underlying)
Holdings
  • common shares

    1,833
  • Stock Options

    Exercise: $5.04From: 2021-04-15Exp: 2026-04-15Common Shares (4,000 underlying)
    4,000
  • Stock Options

    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08Common Shares (8,000 underlying)
    25,000
  • Stock Options

    Exercise: $5.04From: 2022-04-15Exp: 2026-04-15Common Shares (4,000 underlying)
    8,000
  • Stock Options

    Exercise: $5.04From: 2023-04-15Exp: 2026-04-15Common Shares (4,000 underlying)
    12,000
  • Stock Options

    Exercise: $5.31From: 2022-04-26Exp: 2026-04-26Common Shares (5,000 underlying)
    17,000
  • Stock Options

    Exercise: $6.23From: 2021-09-01Exp: 2026-09-01Common Shares (10,000 underlying)
    35,000

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT